Bill Nygren - Harris Associates L P
Holding/activity history for Sanofi Aventis (SNY)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2017 Q1 | 0 | 0.00 | Sell 100.00% | 0.26 | SEC | ||
| 2016 Q4 | 3,231,940 | 0.26 | Reduce 1.27% | <0.01 | $40.44 | $130,700,000 | SEC |
| 2016 Q3 | 3,273,405 | 0.25 | Reduce 41.25% | 0.20 | $38.19 | $125,011,000 | SEC |
| 2016 Q2 | 5,572,075 | 0.48 | Add 0.00% | $41.85 | $233,191,000 | SEC | |
| 2016 Q1 | 5,571,835 | 0.43 | Reduce 3.52% | 0.02 | $40.16 | $223,765,000 | SEC |
| 2015 Q4 | 5,775,040 | 0.43 | Reduce 2.33% | 0.01 | $42.65 | $246,306,000 | SEC |
| 2015 Q3 | 5,912,950 | 0.50 | Add 0.06% | <0.01 | $47.47 | $280,688,000 | SEC |
| 2015 Q2 | 5,909,550 | 0.48 | Add 0.09% | <0.01 | $49.53 | $292,700,000 | SEC |
| 2015 Q1 | 5,904,050 | 0.47 | Add 0.14% | <0.01 | $49.44 | $291,896,000 | SEC |
| 2014 Q4 | 5,895,950 | 0.43 | Add 0.62% | <0.01 | $45.61 | $268,914,000 | SEC |
| 2014 Q3 | 5,859,450 | 0.56 | Add 16.59% | 0.08 | $56.43 | $330,649,000 | SEC |
| 2014 Q2 | 5,025,750 | 0.46 | Add 90.26% | 0.22 | $53.17 | $267,219,000 | SEC |
| 2014 Q1 | 2,641,500 | 0.25 | Buy | 0.25 | $52.28 | $138,098,000 | SEC |